Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild‐to‐Moderate <scp>COVID</scp> ‐19 Cases in a Broadly Immune PopulationHadar Mudrik‐Zohar, Steven Y. C. Tong, Allen Cheng et al.|The Medical Journal of Australia|2026Cited by 0